Sunrest Lifescience Limited (NSE:SUNREST)

Market Cap	141.61M
Revenue (ttm)	520.34M
Net Income (ttm)	17.60M
Shares Out	4.29M
EPS (ttm)	4.10
PE Ratio	8.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,200
Average Volume	4,320
Open	32.00
Previous Close	30.50
Day's Range	32.00 - 33.00
52-Week Range	29.55 - 75.00
Beta	-0.33
RSI	37.48
Earnings Date	Feb 12, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 210
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUNREST

Financial Performance

In 2024, Sunrest Lifescience's revenue was 334.13 million, an increase of 13.33% compared to the previous year's 294.83 million. Earnings were 20.05 million, an increase of 788.48%.